[HTML][HTML] QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-ABCA1 pathway

J Xie, L Peng, C Yang, N Chen, X Feng, T Wu… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance QiShenYiQi pill (QSYQ), a Chinese compound medicine,
originate from BuYangHuanWu decoction in the Qing dynasty, and has been used to treat …

[HTML][HTML] QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver

T Wang, C Yang, L Peng, L Li, N Chen, X Feng, J Xie… - Phytomedicine, 2024 - Elsevier
Background Tetranucleotide repeat domain protein 39B (TTC39B) was found to combine
with ubiquitin ligase E3, and promote the ubiquitination modification of liver X receptor …

[HTML][HTML] QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion

L Peng, CS Lv, Y Zhao, SD Chen, Y Huang, DW Lu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective The aim of this study was to explore potential immunoregulatory mechanisms
underlying the suppressive effect on atherosclerosis of QiShenYiQi pill (QSYQ). Methods …

[HTML][HTML] Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARγ to Regulate Cholesterol Efflux and Endothelial Cell Inflammation

M Wang, Q Xiang, W Sun, H Zhang, R Shi… - … Medicine and Cellular …, 2022 - hindawi.com
At present, due to the limitations of drug therapy targets for atherosclerosis, some patients
fail to achieve satisfactory efficacy. Cholesterol efflux dysfunction and endothelial cell …

Tiaogan daozhuo formula attenuates atherosclerosis via activating AMPK-PPARγ-LXRα pathway

Y Zhang, M Zeng, X Zhang, Q Yu, L Wang… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Tiaogan Daozhuo Formula (TGDZF) is a common
formulation against atherosclerosis, however, there is limited understanding of its …

Xinxuekang regulates reverse cholesterol transport by improving high-density lipoprotein synthesis, maturation, and catabolism

G Dong, W Li, R Wang, W Zou… - Journal of …, 2017 - journals.lww.com
Di'ao Xinxuekang (XXK) is an herbal product in China and the Netherlands that has been
clinically shown to attenuate atherosclerosis; however, the underlying antiatherosclerotic …

Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4/MyD88/NF-κB pathway …

Y Li, L Zhang, P Ren, Y Yang, S Li, X Qin, M Zhang… - Phytomedicine, 2021 - Elsevier
Background Atherosclerosis is a progressive chronic disease characterised by aberrant lipid
metabolism and a maladaptive inflammatory response. As atherosclerosis-driven …

Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction

D Jia, M Zhao, X Zhang, X Cheng, Q Wei, L Lou… - Journal of …, 2024 - Elsevier
Ethnopharmacological relevance The process of atherosclerosis (AS) is complicated.
Transcriptomics technology can assist in discovering the underlying mechanisms and …

Radix Saposhnikoviae enhancing Huangqi Chifeng Decoction improves lipid metabolism in AS mice

J Fu, Y Liang, D Yu, Y Wang, F Lu, S Liu - Journal of Ethnopharmacology, 2024 - Elsevier
Abstract Ethnopharmacological relevance Huangqi Chifeng decoction (HQCF) combined
with parsnips is a classic Chinese traditional medicine formula that has certain advantages …

Qingre Huoxue Decoction regulates macrophage polarisation to attenuate atherosclerosis through the inhibition of NF-κB signalling-mediated inflammation

Z Jin, Y Luo, H Zhao, J Cui, W He, J Li, J Pi… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Atherosclerosis (AS) is a common pathogenesis of
cardiovascular diseases. Qingre Huoxue Decoction (QRHX) is an herbal formula used for …